Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
University of Nebraska
Adela, Inc
Cancer Research UK
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Tempus AI
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
University Health Network, Toronto
BerGenBio ASA
Stanford University
Taproot Health
Vector Vitale LLC
Cedars-Sinai Medical Center
Sanguine Biosciences
OHSU Knight Cancer Institute
Sumitomo Pharma America, Inc.
Blue Note Therapeutics
Hospital Universitario San Ignacio
Weprom
Seoul National University Hospital
First Affiliated Hospital of Wenzhou Medical University
Chinese PLA General Hospital
Shenzhen BinDeBio Ltd.
CureOne
National Institutes of Health Clinical Center (CC)
Butler Hospital
University of Kansas Medical Center
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fox Chase Cancer Center
Stanford University
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)